ANL 10.64 Decreased By ▼ -0.64 (-5.67%)
ASC 9.19 Decreased By ▼ -0.31 (-3.26%)
ASL 11.16 Decreased By ▼ -0.08 (-0.71%)
AVN 76.15 Decreased By ▼ -1.86 (-2.38%)
BOP 5.45 Decreased By ▼ -0.06 (-1.09%)
CNERGY 5.34 Decreased By ▼ -0.07 (-1.29%)
FFL 6.64 Decreased By ▼ -0.12 (-1.78%)
FNEL 5.83 Decreased By ▼ -0.08 (-1.35%)
GGGL 11.11 Decreased By ▼ -0.19 (-1.68%)
GGL 16.39 Decreased By ▼ -0.39 (-2.32%)
GTECH 8.56 Decreased By ▼ -0.43 (-4.78%)
HUMNL 6.86 Decreased By ▼ -0.34 (-4.72%)
KEL 2.92 Decreased By ▼ -0.04 (-1.35%)
KOSM 3.20 Decreased By ▼ -0.26 (-7.51%)
MLCF 26.88 Decreased By ▼ -0.27 (-0.99%)
PACE 2.92 Decreased By ▼ -0.18 (-5.81%)
PIBTL 5.97 Decreased By ▼ -0.14 (-2.29%)
PRL 17.02 Decreased By ▼ -1.04 (-5.76%)
PTC 7.00 Decreased By ▼ -0.08 (-1.13%)
SILK 1.17 Decreased By ▼ -0.02 (-1.68%)
SNGP 36.44 Increased By ▲ 1.69 (4.86%)
TELE 10.65 Decreased By ▼ -0.29 (-2.65%)
TPL 9.09 Decreased By ▼ -0.31 (-3.3%)
TPLP 20.09 Decreased By ▼ -0.40 (-1.95%)
TREET 28.70 Decreased By ▼ -0.70 (-2.38%)
TRG 76.42 Decreased By ▼ -1.08 (-1.39%)
UNITY 19.88 Decreased By ▼ -0.48 (-2.36%)
WAVES 12.78 Decreased By ▼ -0.02 (-0.16%)
WTL 1.36 Decreased By ▼ -0.01 (-0.73%)
YOUW 5.13 Decreased By ▼ -0.38 (-6.9%)
BR100 4,089 Decreased By -28 (-0.68%)
BR30 14,986 Decreased By -82.3 (-0.55%)
KSE100 41,367 Decreased By -263.2 (-0.63%)
KSE30 15,744 Decreased By -117.1 (-0.74%)

WASHINGTON: Testing in humans of an HIV vaccine that uses messenger RNA technology has begun, the biotech firm Moderna and the International AIDS Vaccine Initiative said Thursday. This Phase 1 trial is being carried out in the United States among 56 healthy adults who are HIV negative.

Despite four decades of research, doctors have yet to develop a vaccine to protect people from the virus that causes AIDS, which kills hundreds of thousands of people around the world each year.

Moderna begins trial of Omicron-specific vaccine booster

But hopes have been stirred with the success of mRNA technology, which allowed for the development of Covid-19 vaccines in record time, including one from Moderna.

Comments

Comments are closed.